Literature DB >> 27708943

Propylthiouracil-induced alveolar hemorrhage.

Bünyamin Aydın1, Oğuzhan Aksu1, Hasret Kacemer2, Halil Demirkan1, Atilla Altuntaş3, Nigar Dirican4, Banu Kale Köroğlu1, Mehmet Şahin5.   

Abstract

Thionamide induced vasculitis is a multisystem disease. The patients may present with different clinical signs and findings due to organ involvement. These patients are almost always perinuclear antineutrophil cytoplasmic antibody (pANCA) or antimyeloperoxidase (MPO) positive. Clinical findings are not seen in all of the patients who are ANCA positive while using thionamide. Although symptoms usually resolve with drug discontinuation, some patients, however, require high-dose steroids, immunosuppressants, or plasmapheresis. We present here a case of alveolar hemorrhage induced by propilthiouracil (PTU) during treatment with PTU for Graves' disease; patients completely recovered with corticosteroid, cyclophosphamide, and plasmapheresis.

Entities:  

Keywords:  ANCA; Vasculitis; propylthiouracil

Year:  2015        PMID: 27708943      PMCID: PMC5047252          DOI: 10.5152/eurjrheum.2015.0079

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  11 in total

Review 1.  Antithyroid drugs.

Authors:  David S Cooper
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

Review 2.  Clinical case seminar: Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature.

Authors:  J E Gunton; J Stiel; R J Caterson; A McElduff
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

3.  Neutrophils and drug metabolism.

Authors:  S von Schmiedeberg; C Goebel; E Gleichmann; J Uetrecht
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

4.  Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils.

Authors:  X Jiang; G Khursigara; R L Rubin
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

Review 5.  Central nervous system vasculitis caused by propylthiouracil therapy: a case report and literature review.

Authors:  C Vanek; M H Samuels
Journal:  Thyroid       Date:  2005-01       Impact factor: 6.568

6.  Mechanism of inactivation of myeloperoxidase by propylthiouracil.

Authors:  E Lee; Y Miki; H Katsura; K Kariya
Journal:  Biochem Pharmacol       Date:  1990-05-01       Impact factor: 5.858

7.  Human myeloperoxidase and thyroid peroxidase, two enzymes with separate and distinct physiological functions, are evolutionarily related members of the same gene family.

Authors:  S Kimura; M Ikeda-Saito
Journal:  Proteins       Date:  1988

8.  Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.

Authors:  J Y Noh; T Asari; N Hamada; F Makino; N Ishikawa; Y Abe; K Ito; K Ito
Journal:  Clin Endocrinol (Oxf)       Date:  2001-05       Impact factor: 3.478

9.  Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy.

Authors:  K M Dolman; R O Gans; T J Vervaat; G Zevenbergen; D Maingay; R E Nikkels; A J Donker; A E von dem Borne; R Goldschmeding
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

Review 10.  Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease.

Authors:  M Pillinger; R Staud
Journal:  Semin Arthritis Rheum       Date:  1998-10       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.